XML 26 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)
Ordinary shares
CNY (¥)
shares
Ordinary shares
USD ($)
shares
Additional paid-in capital
CNY (¥)
Additional paid-in capital
USD ($)
Statutory reserves
CNY (¥)
Statutory reserves
USD ($)
Accumulated other comprehensive (loss) income
CNY (¥)
Accumulated other comprehensive (loss) income
USD ($)
Accumulated deficit
CNY (¥)
Accumulated deficit
USD ($)
Equity (deficit) attributable to The9 limited
CNY (¥)
Equity (deficit) attributable to The9 limited
USD ($)
Noncontrolling interest
CNY (¥)
Noncontrolling interest
USD ($)
CNY (¥)
USD ($)
Balance at Dec. 31, 2019 ¥ 7,969,808   ¥ 2,539,552,478   ¥ 28,071,982   ¥ (3,777,952)   ¥ (3,410,856,231)   ¥ (839,039,915)   ¥ (392,881,777)   ¥ (1,231,921,692)  
Balance (in shares) at Dec. 31, 2019 | shares 112,929,702 112,929,702                            
Net loss                 397,883,388   397,883,388   (3,259,528)   394,623,860  
Currency translation adjustments             (12,900,251)       (12,900,251)   16,417,025   3,516,774  
Change in redemption value of redeemable noncontrolling interest     (1,190,122)               (1,190,122)       (1,190,122)  
Share-based compensation ¥ 2,412,325   52,644,101               55,056,426       55,056,426  
Share-based compensation (in shares) | shares 35,100,000 35,100,000                            
Issuance of ordinary shares ¥ 7,715,668   104,650,533               112,366,201       112,366,201  
Issuance of ordinary shares (in shares) | shares 112,002,660 112,002,660                            
Equity on conversion option of convertible notes     106,026               106,026       106,026  
Reversal of statutory reserves due to disposal of certain subsidiaries         (20,745,422)       20,745,422              
Balance at Dec. 31, 2020 ¥ 18,097,801   2,695,763,016   7,326,560   (16,678,203)   (2,992,227,421)   (287,718,247)   (379,724,280)   (667,442,527)  
Balance (in shares) at Dec. 31, 2020 | shares 260,032,362 260,032,362                            
Net loss                 (411,234,755)   (411,234,755)   (5,590,513)   (416,825,268)  
Currency translation adjustments             3,984,443       3,984,443       3,984,443  
Change in redemption value of redeemable noncontrolling interest                             349,046,548  
Consolidated subsidiary                         795,063   795,063  
Share-based compensation ¥ 5,392,416   144,774,065               150,166,481       150,166,481  
Share-based compensation (in shares) | shares 83,661,205 83,661,205                            
Issuance of ordinary shares ¥ 11,555,004   997,389,251               1,008,944,255       1,008,944,255  
Issuance of ordinary shares (in shares) | shares 176,968,248 176,968,248                            
Purchase of equipment ¥ 3,302,261   140,914,432               144,216,693       144,216,693  
Purchase of equipment (in shares) | shares 50,258,970 50,258,970                            
Issuance of convertible debt ¥ 957,128   25,801,328               26,758,456       26,758,456  
Issuance of convertible debt | shares 14,777,050 14,777,050                            
Conversion of convertible debt into ordinary shares ¥ 1,383,990   45,335,212               46,719,202       46,719,202  
Conversion of convertible debt into ordinary shares (in shares) | shares 21,618,840 21,618,840                            
Exercise of warrants ¥ 5,488,973   60,837,127               66,326,100       66,326,100  
Exercise of warrants (in shares) | shares 84,071,910 84,071,910                            
Disposal of Red5     28,308,324               28,308,324   371,504,338   399,812,662  
Balance at Dec. 31, 2021 ¥ 46,177,573   4,139,122,755   7,326,560   (12,693,760)   (3,403,462,176)   776,470,952   (13,015,392)   763,455,560  
Balance (in shares) at Dec. 31, 2021 | shares 691,388,585 691,388,585                            
Net loss                 (974,859,050)   (974,859,050)   (4,633,205)   (979,492,255)  
Currency translation adjustments             166,220       166,220       166,220 $ 24,100
Consolidated subsidiary                         122,253   122,253  
Share-based compensation     202,345,626               202,345,626       202,345,626  
Issuance of ordinary shares ¥ 193,103   3,218,367               3,411,470       3,411,470  
Issuance of ordinary shares (in shares) | shares 3,931,632 3,931,632                            
Cancellation of ordinary shares ¥ (960,666)   (18,555,648)               (19,516,314)       (19,516,314)  
Cancellation of ordinary shares (in shares) | shares (14,854,090) (14,854,090)                            
Conversion of convertible debt into ordinary shares ¥ 12,193,208   45,097,091               57,290,299       57,290,299  
Conversion of convertible debt into ordinary shares (in shares) | shares 180,578,790 180,578,790                            
Balance at Dec. 31, 2022 ¥ 57,603,218 $ 8,351,682 ¥ 4,371,228,191 $ 633,768,513 ¥ 7,326,560 $ 1,062,251 ¥ (12,527,540) $ (1,816,323) ¥ (4,378,321,226) $ (634,796,906) ¥ 45,309,203 $ 6,569,217 ¥ (17,770,850) $ (2,576,531) ¥ 27,538,353 $ 3,992,686
Balance (in shares) at Dec. 31, 2022 | shares 861,044,917 861,044,917